Ofatumumab
Hazard
-
P
-
B
-
T
-
Risk
Exempt
Information
The use of amino acids, proteins and peptides is not considered to have any environmental impact. Arzerra (ofatumumab) is now withdrawn from use in Sweden since 2019-02-28.
Author: The Pharmaceutical unit of Region Stockholm